Exponent (EXPO) Common Equity (2010 - 2026)

Exponent has disclosed Common Equity across 17 years of filings, most recently posting $338.3 million for Q2 2026.

• Quarterly Common Equity fell 23.35% year-over-year to $338.3 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $338.3 million (down 23.35% YoY) and the FY2026 annual result came in at $390.3 million, down 7.3% from the prior year.
• Common Equity fell to $338.3 million in Q2 2026, from $390.3 million in the prior quarter.
• Over five years, Common Equity peaked at $441.4 million in Q2 2025 and troughed at $319.8 million in Q3 2022.
• A 5-year average of $374.9 million and a median of $374.3 million in 2024 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2025 — Common Equity gained 18.25% — and 2026, when it retreated 23.35%.
• Tracing EXPO's Common Equity over 5 years: stood at $320.8 million in 2022, then increased by 11.02% to $356.1 million in 2023, then advanced by 15.22% to $410.3 million in 2024, then slipped by 1.81% to $402.9 million in 2025, then decreased by 16.02% to $338.3 million in 2026.
• Business Quant data shows EXPO's Common Equity at $338.3 million in Q2 2026, $390.3 million in Q1 2026, and $402.9 million in Q4 2025.